FinUniversity Electronic Library

     

Details

Advances in Alzheimer's disease (Series) ;.
Alzheimer's disease: new beginnings. — v. 6. / edited by George Perry [and four others]. — 1 online resource (ix, 670 pages). — (Advances in alzheimer's disease). — <URL:http://elib.fa.ru/ebsco/1876779.pdf>.

Record create date: 8/24/2018

Subject: Alzheimer's disease.; HEALTH & FITNESS / Diseases / General.; MEDICAL / Clinical Medicine.; MEDICAL / Diseases.; MEDICAL / Evidence-Based Medicine.; MEDICAL / Internal Medicine.; Alzheimer's disease.

Collections: EBSCO

Allowed Actions:

Action 'Read' will be available if you login or access site from another network Action 'Download' will be available if you login or access site from another network

Group: Anonymous

Network: Internet

Document access rights

Network User group Action
Finuniversity Local Network All Read Print Download
Internet Readers Read Print
-> Internet Anonymous

Table of Contents

  • Title Page
  • Preface
  • Contents
  • Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future
  • Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
  • Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies
  • The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View
  • Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
  • Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease
  • Dementia Research: Populations, Progress, Problems, and Predictions
  • Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers
  • Religious Orders Study and Rush Memory and Aging Project
  • Prevention Matters: Time for Global Action and Effective Implementation
  • Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle
  • Preclinical Alzheimer's Disease: Implications for Refinement of the Concept
  • Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review
  • The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease
  • From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease
  • Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment
  • A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations
  • Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
  • Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease
  • Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation
  • Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET
  • Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy
  • Conquering Alzheimer's Disease by Self Treatment
  • Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease
  • Iron and Alzheimer's Disease: An Update on Emerging Mechanisms
  • Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
  • Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches
  • Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions
  • Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease
  • Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases
  • Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase
  • Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation
  • Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease
  • Our Tau Tales from Normal to Pathological Behavior
  • Amyloid-Beta and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies
  • New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy
  • Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation
  • The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
  • Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
  • The Amyloid-Beta Oligomer Hypothesis: Beginning of the Third Decade
  • Role of Amyloid-Beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade
  • Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease
  • Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration
  • Amyloid-Beta/Drug Interactions from Computer Simulations and Cell-Based Assays

Usage statistics

stat Access count: 0
Last 30 days: 0
Detailed usage statistics